SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Oppenheimer Initiates Coverage On Aldeyra Therapeutics with Outperform Rating, Announces Price Target of $12

Oppenheimer initiates coverage on Aldeyra Therapeutics (NASDAQ:ALDX) with a Outperform rating and announces Price Target of $12.

Benzinga · 05/12/2020 10:28

Oppenheimer initiates coverage on Aldeyra Therapeutics (NASDAQ:ALDX) with a Outperform rating and announces Price Target of $12.